Connett, John |
PACBACK, NCT03581123: Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain |
|
|
| Completed | 3 | 1000 | US | Supported-Self Management (SSM), Spinal Manipulation Therapy (SMT), SMT + SSM, Standard Medical Care (SMC) | University of Minnesota, University of Pittsburgh, University of Washington, University of North Texas Health Science Center, Oregon Health and Science University, Duke University | Acute Pain, Low Back Pain, Mechanical | 06/24 | 06/24 | | |
Gordin, Fred |
NCT01056185: Respiratory Virus Hospitalization Study (FLU 003 Plus) |
|
|
| Completed | N/A | 1000 | Europe, US, RoW | | University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Clinical & Translational Science Institute, University of Minnesota | Influenza, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) | 08/24 | 08/24 | | |
Benator, Debra |
ASTERoiD, NCT03474029: Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI |
|
|
| Recruiting | 2/3 | 3400 | Canada, US, RoW | Rifapentine daily for 6 weeks, priftin, Rifapentine and Isoniazid weekly for 12 weeks, Rifampin and Isoniazid daily for 12 weeks, Rifampin daily for 16 weeks | Centers for Disease Control and Prevention, British Medical Research Council | Latent Tuberculosis | 12/29 | 12/29 | | |
| Recruiting | N/A | 753 | US | PositiveLinks | George Washington University, National Institute of Mental Health (NIMH), University of Virginia | HIV/AIDS | 04/25 | 06/25 | | |
DC Cohort, NCT01206920: Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: the |
|
|
| Recruiting | N/A | 15000 | US | | George Washington University, National Institute of Allergy and Infectious Diseases (NIAID) | HIV, AIDS | 01/41 | 01/41 | | |
Simon, Gary |
NCT01056185: Respiratory Virus Hospitalization Study (FLU 003 Plus) |
|
|
| Completed | N/A | 1000 | Europe, US, RoW | | University of Minnesota, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Clinical & Translational Science Institute, University of Minnesota | Influenza, Novel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV), Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) | 08/24 | 08/24 | | |
Weintrob, Amy |
GLORI, NCT04036058: Effect of Expanding (Gloving) Barrier Precautions for Reducing Clostridium Difficile Acquisition (and Infection) in VA |
|
|
| Active, not recruiting | N/A | 10 | US | Universal gloving, Expanded barrier precautions | VA Office of Research and Development, University of Wisconsin, Madison | Clostridium Difficile | 12/23 | 09/24 | | |
Lee, Mary |
| Active, not recruiting | 3 | 187 | Canada, US | Escitalopram, Lexapro, Placebo, non-applicable | JHSPH Center for Clinical Trials, National Institute on Aging (NIA) | Dementia | 04/24 | 05/25 | | |
NCT02124174: Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS |
|
|
| Recruiting | 2 | 50 | US | Vidaza and Valproic Acid, Vidaza, Valproic Acid, Azacitadine | Patrick Stiff | Acute Myelogenous Leukemia AML, Myelodysplastic Syndrome MDS | 01/22 | 01/22 | | |
LIFU_TUD, NCT06405074: Low Intensity Focused Ultrasound for Tobacco Use Disorder: High Resolution Targeting of the Human Insula |
|
|
| Recruiting | N/A | 44 | US | low intensity focused ultrasound (LIFU) | Washington D.C. Veterans Affairs Medical Center | Tobacco Use Disorder | 03/26 | 03/26 | | |
| Recruiting | N/A | 25 | US | low intensity focused ultrasound (LIFU) | Washington D.C. Veterans Affairs Medical Center, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA) | Opioid Use Disorder, Chronic Back Pain, Anxiety | 09/25 | 09/25 | | |
Kunisaki, Ken M |
NCT05119556: Video Telehealth Pulmonary Rehabilitation to Reduce Hospital Readmission in Chronic Obstructive Pulmonary Disease |
|
|
| Recruiting | N/A | 768 | US | Video Telehealth Pulmonary Rehabilitation | University of Alabama at Birmingham, National Heart, Lung, and Blood Institute (NHLBI) | Chronic Obstructive Pulmonary Disease | 06/26 | 08/27 | | |
Harris-Love, Michael |
| Active, not recruiting | N/A | 136 | US | Eccentric Exercise, Negative work training, Concentric Exercise, Conventional strength training | VA Office of Research and Development | Sarcopenia | 08/22 | 09/23 | | |
EMPHASIS, NCT06607913: Exercise and Monitoring With Post-Hospitalization Muscle Atrophy to Sustain Intrinsic Capacity and Strength |
|
|
| Not yet recruiting | N/A | 250 | US | Exercise | VA Office of Research and Development | Chronic Kidney Disease (CKD) | 09/28 | 09/29 | | |
Quinones, Mercedes |
MOVE-OK, NCT05035810: A Pragmatic Trial to Determine the Benefit of Behaviorally Enhanced Exercise Incentives and Corticosteroid Injections in Osteoarthritis of the Knee Marching On for Veterans With Osteoarthritis of the Knee |
|
|
| Active, not recruiting | 3 | 221 | US | Social Incentives and Gamification to Promote Exercise, Corticosteroid Injection given in A-B order, No Social Incentive applied, Procedure: Corticosteroid Injection given in B-A order | VA Office of Research and Development | Osteoarthritis of the Knee | 11/24 | 12/25 | | |
Cabrera, Roniel |
NCT03878550: Case-Control Study of the Glycotest™ HCC Panel vs AFP for the Detection of Early-stage Hepatocellular Carcinoma |
|
|
| Active, not recruiting | N/A | 766 | US, RoW | | Glycotest, Inc. | Carcinoma, Hepatocellular, Cirrhosis, Liver | 08/23 | 12/24 | | |
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk |
|
|
| Recruiting | N/A | 2500 | US | Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test | Exact Sciences Corporation | Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer | 01/25 | 04/26 | | |
| Recruiting | N/A | 1260 | US | Palliative Care | Albert Einstein Healthcare Network, Patient-Centered Outcomes Research Institute | End Stage Liver Disease | 07/24 | 05/25 | | |
Liappis, Angelike |
| Recruiting | 4 | 880 | US | Rifampin, Riboflavin Placebo | VA Office of Research and Development | Osteomyelitis, Diabetes, Amputation | 09/25 | 09/25 | | |
Gollie, Jared M |
| Recruiting | N/A | 52 | US | Minimal-Dose Home-Based Resistance Exercise | VA Office of Research and Development | Long COVID | 06/25 | 06/25 | | |
NCT04397159: Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease |
|
|
| Recruiting | N/A | 30 | US | Combination Exercise, Flywheel Resistance Plus Aerobic Exercise | VA Office of Research and Development | Chronic Kidney Disease Predialysis | 04/26 | 04/26 | | |
Cummins, Shirley |
| Recruiting | 4 | 880 | US | Rifampin, Riboflavin Placebo | VA Office of Research and Development | Osteomyelitis, Diabetes, Amputation | 09/25 | 09/25 | | |
Escorcia, Freddy E |
| Recruiting | 2 | 50 | US | F18-FDG, MRI, CT, F18-DCFPyL | National Cancer Institute (NCI) | Hepatocellular Carcinoma | 06/25 | 12/25 | | |
Gunawan, Claudia |
| Active, not recruiting | 3 | 187 | Canada, US | Escitalopram, Lexapro, Placebo, non-applicable | JHSPH Center for Clinical Trials, National Institute on Aging (NIA) | Dementia | 04/24 | 05/25 | | |
Huynh, Nguyen |
NCT06448052: Umbilical Cord Mesenchymal Stem Cell for Aging-related Low-grade Inflammation |
|
|
| Active, not recruiting | 1/2 | 72 | RoW | umbilical cord mesenchymal stem cell | Nguyen Ton Ngoc Huynh | Inflammatory Disease, Aging Problems, Obese, Lipid Metabolism Disorders, Diabetes | 01/26 | 10/26 | | |
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk |
|
|
| Recruiting | N/A | 2500 | US | Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test | Exact Sciences Corporation | Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer | 01/25 | 04/26 | | |
Navo, Roxanne |
ALTUS, NCT05064553: Performance of a Multi- Target Hepatocellular Carcinoma (HCC) Test in Subjects With Increased Risk |
|
|
| Recruiting | N/A | 2500 | US | Study CT/MRI Imaging, Standard of Care CT/MRI Imaging, Oncoguard™ Liver Test | Exact Sciences Corporation | Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatitis B, Cirrhosis, Liver Cancer | 01/25 | 04/26 | | |